Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients

• Status: Terminated
• Trial end date: 2002-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to evaluate the safety of risperidone treatment in acute psychotic patients that require an admission into emergency department. The effectiveness of risperidone in controlling acute psychotic symptomatology and incidence, severity and risk of psychomotor agitation in acute psychotic patients was also studied.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Janssen-Cilag, S.A.
• Treatments: Risperidone

Criteria

Inclusion Criteria:

• Acute Psychotic symptoms in Schizophrenia

• Schizoaffective disorder and Schizophreniform disorders in patients that required an admission into a hospital and in which physicians considered the use of risperidone as treatment under clinical practice

Exclusion Criteria:

• Pregnant or lactating patients

• Patients with psychiatry pathology other than Schizophrenia or schizoaffective disorder

• Patients with neurology pathology except Parkinsonism induced by neuroleptics

• Patients with other severe concomitant pathology

• Patients treated with risperidone in the last 30 days